AI predicts heart artery changes after stenting
Part of Heart & circulation clinical trials.
This study uses artificial intelligence to predict how heart arteries might change after a stent procedure (PCI). Researchers will collect blood samples and medical data to develop a tool that could help doctors make better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had or will have a heart stent procedure (PCI)
- A blood sample can be taken
- You are not pregnant or breastfeeding
- You do not have severe liver or kidney disease
- You do not have an active autoimmune disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new artificial intelligence (AI) tool that helps doctors understand and manage coronary heart disease. The tool uses patient data to provide better care. Your participation will help improve this tool for future patients.
This study uses an artificial intelligence system that analyzes a photograph of your retina (the back of your eye) to predict your risk of developing coronary heart disease in the future. It is for people who do not have major health problems and are not currently taking statins or have known heart disease.
This trial uses artificial intelligence to analyze heart ultrasound images and detect blocked arteries in people with suspected coronary artery disease. It aims to see if AI can accurately find problems without needing more invasive tests.
This trial uses an artificial intelligence model to analyze images and data from people who have had a heart attack and received a stent. The goal is to find patterns that can predict future problems early, so doctors can tailor care.
This trial uses artificial intelligence to analyze ECG results and timing in patients with a type of heart attack called Non-STEMI (where the artery is narrowed but not fully blocked). The goal is to see if AI can help predict damage and outcomes, which could lead to better care.
This trial tests an artificial-intelligence tool that uses a heart ultrasound to help guide stent treatment. It may help doctors choose the best way to treat blockages and improve stent results for people with symptoms from reduced blood flow to the heart.
Hear when a new Coronary Heart Disease (CHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.